Busey Bank Boosts Stake in Colgate-Palmolive (NYSE:CL)

Busey Bank raised its position in shares of Colgate-Palmolive (NYSE:CL) by 1.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 167,988 shares of the company’s stock after buying an additional 2,073 shares during the quarter. Busey Bank’s holdings in Colgate-Palmolive were worth $15,272,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the company. D Orazio & Associates Inc. boosted its position in shares of Colgate-Palmolive by 3.9% during the 3rd quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock valued at $297,000 after acquiring an additional 108 shares during the last quarter. Fiducient Advisors LLC lifted its position in Colgate-Palmolive by 5.2% during the third quarter. Fiducient Advisors LLC now owns 2,231 shares of the company’s stock valued at $232,000 after purchasing an additional 110 shares during the last quarter. Sequoia Financial Advisors LLC grew its stake in shares of Colgate-Palmolive by 0.6% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company’s stock worth $2,117,000 after buying an additional 113 shares in the last quarter. Great Waters Wealth Management increased its holdings in shares of Colgate-Palmolive by 1.5% in the 3rd quarter. Great Waters Wealth Management now owns 7,669 shares of the company’s stock worth $796,000 after buying an additional 117 shares during the last quarter. Finally, Waldron Private Wealth LLC raised its position in shares of Colgate-Palmolive by 2.1% during the 3rd quarter. Waldron Private Wealth LLC now owns 5,632 shares of the company’s stock valued at $585,000 after buying an additional 118 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently commented on the company. UBS Group dropped their price target on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a research report on Thursday, January 16th. Stifel Nicolaus decreased their price target on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a report on Friday, January 17th. JPMorgan Chase & Co. dropped their price objective on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a research note on Thursday, January 16th. StockNews.com downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $101.00 price target on shares of Colgate-Palmolive in a research note on Wednesday. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have given a buy rating to the company’s stock. According to data from MarketBeat, Colgate-Palmolive currently has an average rating of “Hold” and an average target price of $102.00.

Colgate-Palmolive Stock Down 0.2 %

NYSE:CL opened at $89.65 on Thursday. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The firm has a market cap of $73.24 billion, a PE ratio of 25.69, a price-to-earnings-growth ratio of 3.59 and a beta of 0.44. The company has a 50-day moving average of $91.67 and a 200 day moving average of $97.34. Colgate-Palmolive has a 1-year low of $82.68 and a 1-year high of $109.30.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.23%. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.34% of the stock is owned by insiders.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.